Aortic sclerosis - A marker of coronary atherosclerosis

Clinical Cardiology

Volumn 27, Issue 12, 2004, Pages 671-673

  Prasad, Yogendra ^a   Bhalodkar, Narendra C ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Aortic valve sclerosis; Cardiovascular events; Coronary atherosclerosis; Risk modification

Indexed keywords

CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METALLOPROTEINASE;

AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE; ARTERY CALCIFICATION; BLOOD FLOW; CALCIFICATION; CARDIOVASCULAR RISK; CAROTID ARTERY PULSE; CORONARY ARTERY ATHEROSCLEROSIS; DEATH; DIABETES MELLITUS; DISEASE COURSE; DISEASE MARKER; ECHOCARDIOGRAPHY; GERIATRICS; HEART INFARCTION; HEART SOUND; HYPERTENSION; INCIDENCE; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC HEART MURMUR;

EID: 10044284104     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960271202     Document Type: Review

References (24)

1. Lindroos M, Kupari M, Heikkila J, Tilvis R: Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225
2. Gardin JM, Wong ND, Bommer W, Klopfenstein HS, Smith VE, Tabatznik B, Siscovick D, Lobodzinski S, Anton-Culver H, Manolio TA: Echocardiographic design of a multicenter investigation of free-living elderly subjects: The Cardiovascular Health Study. J Am Soc Echocardiogr 1992;5:63-72 [Erratum, J Am Soc Echocardiogr 1992;5:550.]
3. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634
4. Deutscher S, Rockette HE, Krishnaswami V: Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chron Dis 1984;37:407-415
5. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, Nagoh N, Kayaba K, Yamada S, Matsuo H: Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995;76:928-932
6. Aronow WS, Schwartz KS, Koenigsberg M: Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987;59:998-999
7. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM: Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of "degenerative" valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-532
8. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM: Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2163-2168
9. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J: Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-1170
10. Olsson M, Rosenqvist M, Nilsson J: Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol 1994;24:1664-1671
11. Boon A, Cheriex E, Lodder J, Kessels F: Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-474
12. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A: The Cardiovascular HealthStudy: Design and rationale. Ann Epidemiol 1991;1:263-276
13. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147
14. Teerlink JR, Newman TB, Schiller NB, Foster E: Aortic sclerosis, as well as aortic stenosis, is a significant predictor of mortality (abstr). Circulation 1997;96;(suppl I):I-82
15. Aronow S, Ahn C, Kronzon I: Association of mitral annular calcium and of aortic cuspal calcium with coronary artery disease in older patients. Am J Cardiol 1999;84:1084-1085
16. Carabello BA: Aortic sclerosis - window to the coronary arteries? N Engl J Med 1999;341:193-195
17. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E: Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003;Jan 1:41(1):136-141
18. Adler Y, Vaturi M, Herz I, Iakobishvili Z, Toaf J, Fink N, Battler A, Sagie A: Nonobstructive aortic valve calcification: A window to significant coronary artery disease. Atherosclerosis 2002;161:193-197
19. Fox CSD, Vasan RS, Parise H, Levy D, O'Donnell CJ, D'Agostino RB, Benjamin EJ: Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham Heart Study. Circulation 2003;107(11): 1492-1496
20. Otto CM, Burwash IG, Legget ME, Munt BE, Fujioka M, Healy NL, Kraft CD, Miyake-Hull CY, Schwaegler RG: Prospective study of asymptomatic valvular aortic stenosis: Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-2270
21. Otto CM, Pearlman AS, Gardner CL: Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. J Am Coll Cardiol 1989;13:545-550
22. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H: Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-617
23. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998;Dec 31, 339:1972-1978
24. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O'Brien KD: HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 2002;359(9312):1125-1126